Reliance Industries, through its healthcare arm, and Capri Global Capital have jointly acquired Mumbai’s SevenHills Hospital in a high-value transaction that strengthens their foothold in India’s premium tertiary care segment. The deal includes the 1,500-bed multi specialty facility and its associated land and infrastructure, positioning the partners to expand advanced care services, introduce new centres of excellence, and integrate digital health capabilities across the hospital network.
Glimpse:
The acquisition, finalised on January 25, 2026, values SevenHills Hospital at approximately ₹2,500–3,000 crore. Reliance and Capri Global plan to invest further in upgrading clinical infrastructure, adding cutting-edge technology (including robotic surgery and AI diagnostics), and expanding specialty departments such as oncology, cardiology, neurosciences, and organ transplantation. The move aligns with Reliance’s broader healthcare ambitions and Capri Global’s strategy to diversify into high growth real assets while improving healthcare access in one of India’s most competitive markets.
Reliance Industries Limited and Capri Global Capital have jointly acquired Mumbai’s prominent SevenHills Hospital in a landmark transaction that signals deepening private sector investment in India’s tertiary healthcare space. The deal, completed on January 25, 2026, transfers full ownership of the 1,500-bed multi specialty facility including its prime Andheri location, land parcel, and existing clinical infrastructure to the partnership.
SevenHills Hospital, known for its strong presence in cardiac sciences, oncology, neurosciences, and organ transplantation, has been a significant player in Mumbai’s private healthcare ecosystem. The acquisition provides Reliance and Capri Global with immediate scale in a high demand metropolitan market while offering a platform for further expansion of advanced care services.
The partners plan to invest substantially post acquisition to modernise clinical and operational capabilities. Priorities include:
- Upgrading diagnostic and imaging infrastructure with AI-enabled tools
- Introducing robotic-assisted surgery suites and advanced interventional facilities
- Expanding centres of excellence in oncology, cardiology, neurosciences, and transplant medicine
- Integrating digital health solutions for seamless patient journeys, teleconsultations, and remote monitoring
- Enhancing preventive and wellness programmes to attract domestic and international patients
The transaction reflects Reliance’s strategic push into healthcare delivery as part of its broader consumer and health ecosystem ambitions, while Capri Global sees the hospital as a high-quality real asset with strong cash-flow potential and long-term appreciation in one of Mumbai’s most desirable micro-markets.
A senior spokesperson from Reliance stated: “This acquisition aligns with our vision of building integrated, technology enabled healthcare ecosystems that deliver world class outcomes. SevenHills gives us an immediate platform to accelerate innovation and access in a key metropolitan region.”
Capri Global leadership added: “Hospitals like SevenHills represent stable, high-impact assets in a growing sector. We are excited to partner with Reliance to unlock greater value through operational excellence and strategic investments.”
The deal is expected to close fully in the coming months following regulatory clearances. SevenHills Hospital will continue operations without interruption, with existing management and clinical teams retained during the transition. The acquisition is viewed as a positive signal for the Indian healthcare market, where private capital is increasingly flowing into premium tertiary assets to meet rising demand for advanced care.
“Healthcare delivery in India is at an inflection point. By combining strong clinical assets with technology and capital, we can deliver higher quality care to more people starting right here in Mumbai.”
By
HB Team
Related News
